LifeSci Capital Downgrades Nuvalent to Market Perform, Announces $124 Price Target

Benzinga Newsdesk www.benzinga.com Negative 93.4%

Neg 93.4% Neu 0% Pos 0%

LifeSci Capital downgrades Nuvalent (NASDAQ:NUVL) from Outperform to Market Perform and announces $124 price target.

Comments

No comments yet. Be the first!